194 related articles for article (PubMed ID: 33845915)
1. Risk factors for developing severe COVID-19 in China: an analysis of disease surveillance data.
Geng MJ; Wang LP; Ren X; Yu JX; Chang ZR; Zheng CJ; An ZJ; Li Y; Yang XK; Zhao HT; Li ZJ; He GX; Feng ZJ
Infect Dis Poverty; 2021 Apr; 10(1):48. PubMed ID: 33845915
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 disease severity and associated factors among Ethiopian patients: A study of the millennium COVID-19 care center.
Leulseged TW; Abebe KG; Hassen IS; Maru EH; Zewde WC; Chamiso NW; Yegele KT; Bayisa AB; Siyoum DF; Edo MG; Mesfin EG; Derejie MN; Shiferaw HK
PLoS One; 2022; 17(1):e0262896. PubMed ID: 35085338
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.
Li Y; Shang Y; Yang Y; Wang M; Yu D; Su D; Liu L; Wang Q; Zhang X; Ren J; Chen H
Respiration; 2020; 99(9):739-747. PubMed ID: 33207356
[TBL] [Abstract][Full Text] [Related]
4. Determinants of COVID-19 severity in Ethiopia: a multicentre case-control study.
Tadie MB; Yimer YS; Taye G
BMJ Open; 2024 May; 14(5):e083076. PubMed ID: 38803268
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of different subtypes and risk factors for the severity of illness in patients with COVID-19 in Zhejiang, China.
Zhang SY; Lian JS; Hu JH; Zhang XL; Lu YF; Cai H; Gu JQ; Ye CY; Jin CL; Yu GD; Jia HY; Zhang YM; Sheng JF; Li LJ; Yang YD
Infect Dis Poverty; 2020 Jul; 9(1):85. PubMed ID: 32641121
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Severe COVID-19 in Children.
Graff K; Smith C; Silveira L; Jung S; Curran-Hays S; Jarjour J; Carpenter L; Pickard K; Mattiucci M; Fresia J; McFarland EJ; Dominguez SR; Abuogi L
Pediatr Infect Dis J; 2021 Apr; 40(4):e137-e145. PubMed ID: 33538539
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and risk factors for severe inpatients with COVID-19: A retrospective study in China.
Wang J; Guo S; Zhang Y; Gao K; Zuo J; Tan N; Du K; Ma Y; Hou Y; Li Q; Xu H; Huang J; Huang Q; Na H; Wang J; Wang X; Xiao Y; Zhu J; Chen H; Liu Z; Wang M; Zhang L; Wang W
PLoS One; 2020; 15(12):e0244125. PubMed ID: 33332437
[TBL] [Abstract][Full Text] [Related]
8. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative.
Martin B; DeWitt PE; Russell S; Anand A; Bradwell KR; Bremer C; Gabriel D; Girvin AT; Hajagos JG; McMurry JA; Neumann AJ; Pfaff ER; Walden A; Wooldridge JT; Yoo YJ; Saltz J; Gersing KR; Chute CG; Haendel MA; Moffitt R; Bennett TD
JAMA Netw Open; 2022 Feb; 5(2):e2143151. PubMed ID: 35133437
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of 276 hospitalized patients with coronavirus disease 2019 in Zengdu District, Hubei Province: a single-center descriptive study.
Wei Y; Zeng W; Huang X; Li J; Qiu X; Li H; Liu D; He Z; Yao W; Huang P; Li C; Zhu M; Zhong C; Zhu X; Liu J
BMC Infect Dis; 2020 Jul; 20(1):549. PubMed ID: 32727456
[TBL] [Abstract][Full Text] [Related]
10. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
[TBL] [Abstract][Full Text] [Related]
11. Contact Settings and Risk for Transmission in 3410 Close Contacts of Patients With COVID-19 in Guangzhou, China : A Prospective Cohort Study.
Luo L; Liu D; Liao X; Wu X; Jing Q; Zheng J; Liu F; Yang S; Bi H; Li Z; Liu J; Song W; Zhu W; Wang Z; Zhang X; Huang Q; Chen P; Liu H; Cheng X; Cai M; Yang P; Yang X; Han Z; Tang J; Ma Y; Mao C
Ann Intern Med; 2020 Dec; 173(11):879-887. PubMed ID: 32790510
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave.
Sharif N; Opu RR; Ahmed SN; Sarkar MK; Jaheen R; Daullah MU; Khan S; Mubin M; Rahman H; Islam F; Haque N; Islam S; Khan FB; Haque N; Ayman U; Shohael AM; Dey SK; Talukder AA
Diabetes Metab Syndr; 2021; 15(4):102148. PubMed ID: 34186349
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
[TBL] [Abstract][Full Text] [Related]
14. Determination of risk factors for predicting the onset of symptoms in asymptomatic COVID-19 infected patients.
Tao PY; Leng L; Liu K; Zhou RH; Hu YC; Wu SJ; Xiao YD; Liu J
Int J Med Sci; 2020; 17(14):2187-2193. PubMed ID: 32922180
[No Abstract] [Full Text] [Related]
15. Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study.
Tian J; Yan S; Wang H; Zhang Y; Zheng Y; Wu H; Li X; Gao Z; Ai Y; Gou X; Zhang L; He L; Lian F; Liu B; Tong X
Pharmacol Res; 2020 Nov; 161():105127. PubMed ID: 32791263
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study.
Cen Y; Chen X; Shen Y; Zhang XH; Lei Y; Xu C; Jiang WR; Xu HT; Chen Y; Zhu J; Zhang LL; Liu YH
Clin Microbiol Infect; 2020 Sep; 26(9):1242-1247. PubMed ID: 32526275
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for severity of COVID-19 in hospital patients age 18-29 years.
Sandoval M; Nguyen DT; Vahidy FS; Graviss EA
PLoS One; 2021; 16(7):e0255544. PubMed ID: 34329347
[TBL] [Abstract][Full Text] [Related]
18. Comorbidities and clinical features related to severe outcomes among COVID-19 cases in Selangor, Malaysia.
Hasani WSR; Ganapathy SS; Lin CZ; Rifin HM; Bahari MN; Ghazali MH; Lodz NA; Ramli MHT; Majid NLA; Ling MYJ; Yusoff MFM; Ahmad NA; Suleiman A; Yusoff AF; Balan V; Ngadiman S
Western Pac Surveill Response J; 2021; 12(1):46-52. PubMed ID: 34094624
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.
Liang WH; Guan WJ; Li CC; Li YM; Liang HR; Zhao Y; Liu XQ; Sang L; Chen RC; Tang CL; Wang T; Wang W; He QH; Chen ZS; Wong SS; Zanin M; Liu J; Xu X; Huang J; Li JF; Ou LM; Cheng B; Xiong S; Xie ZH; Ni ZY; Hu Y; Liu L; Shan H; Lei CL; Peng YX; Wei L; Liu Y; Hu YH; Peng P; Wang JM; Liu JY; Chen Z; Li G; Zheng ZJ; Qiu SQ; Luo J; Ye CJ; Zhu SY; Cheng LL; Ye F; Li SY; Zheng JP; Zhang NF; Zhong NS; He JX
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32269086
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological and clinical characteristics of 161 discharged cases with coronavirus disease 2019 in Shanghai, China.
Lin S; Pan H; Wu H; Yu X; Cui P; Han R; Jiang C; Kong D; Zheng Y; Gong X; Xiao W; Mao S; Jin B; Zhu Y; Sun X
BMC Infect Dis; 2020 Oct; 20(1):780. PubMed ID: 33081711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
